FLEXISEQ

WIPO WIPO 2011

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark FLEXISEQ was filed as Word mark on 12/12/2011 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1122241
Register number 2585425
Countries Australia Bahrain China Cyprus Israel Iran Iceland Japan Kenya South Korea Liechtenstein Monaco Oman Russia Singapore Turkey Ukraine United States of America (USA) Vietnam
Base trademark GB No. 2585425, June 22, 2011
Application date December 12, 2011
Expiration date December 12, 2031

Trademark owner

4th floor,
Reading Bridge House,
GB

Trademark representatives

Bedford House, John Street London WC1N 2BF GB

goods and services

01 Lipids and surfactants for use in industry and science; surfactants and lipids for use in personal care products, chemical products for in vitro or in vivo use in research and development
05 Pharmaceutical preparations and substances; veterinary and sanitary preparations and substances; chemical preparations for pharmaceutical purposes; diagnostic preparations and substances, all for in vivo use; pharmaceuticals in the field of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; topical and parenteral preparations of vesicles; chemical preparations in the form of vesicles for medical and veterinary purposes; chemical membranes and chemical aggregates for medical and veterinary purposes; preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances; cosmeceutical preparations for medical use; local anaesthetics; steroids; anti-inflammatory drugs; pharmaceuticals for the treatment of nail fungal infections; vaccines; immunotherapeutic vaccines; lipids for topical and parenteral use; creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation; surfactants for use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrhoeic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, such as AMD, or fungal infection and disorders related to fatty acid deficiencies
10 Medical devices for topical use in the treatment of pain; molecular filtering devices for medical use; medical, veterinary and surgical apparatus, instruments and devices; inhalers; injection apparatus, instruments and devices; apparatus, instruments and devices for dispensing medical, surgical and veterinary preparations, dispersions, creams, powders, tablets and pills; instruments and devices for the administration of pain relief therapy and prophylaxis preparations and substances; parts and fittings for all of the aforesaid

Trademark history

Date Document number Area Entry
December 12, 2021 2021/50 Gaz Extension
October 1, 2020 2020/43 Gaz US RAW: Partial Invalidation
April 11, 2017 2017/24 Gaz TM Rejection
January 11, 2017 2017/2 Gaz MX Rejection
October 21, 2016 2016/44 Gaz RU Rejection
October 21, 2016 2017/8 Gaz AM Rejection
October 18, 2016 2017/8 Gaz TJ Rejection
October 18, 2016 2017/8 Gaz TJ Rejection
October 12, 2016 2016/42 Gaz UA Rejection
August 24, 2016 2017/19 Gaz KG Rejection
July 14, 2016 2016/36 Gaz MD Rejection
July 13, 2016 2017/4 Gaz BY Rejection
July 12, 2016 2016/52 Gaz KZ Rejection
September 8, 2015 2015/42 Gaz Correction
November 25, 2014 2014/51 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 6, 2014 2015/3 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 22, 2014 2014/42 Gaz CY RAW: Rule 18ter(2)(i) GP following a provisional refusal
August 5, 2014 2014/35 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 6, 2014 2014/19 Gaz TR Rejection
February 27, 2014 2014/9 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 10, 2014 2014/8 Gaz TM Rejection
October 16, 2013 2014/9 Gaz GE Rejection
September 30, 2013 2013/42 Gaz KE Rejection
September 3, 2013 2013/36 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 21, 2013 2013/35 Gaz KZ Rejection
August 19, 2013 2013/40 Gaz KP RAW: Rule 18ter(2)(i) GP following a provisional refusal
August 1, 2013 2013/31 Gaz MD Rejection
July 31, 2013 2013/39 Gaz VN Rejection
July 31, 2013 2013/32 Gaz IL Rejection
July 25, 2013 2013/34 Gaz KG Rejection
July 4, 2013 2013/27 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 21, 2013 2013/26 Gaz AM Rejection
June 14, 2013 2013/26 Gaz TJ Rejection
April 23, 2013 2013/20 Gaz LI Rejection
March 19, 2013 2013/15 Gaz KP Rejection
March 11, 2013 2013/11 Gaz CN Rejection
February 26, 2013 2013/10 Gaz CY Rejection
January 24, 2013 2013/4 Gaz JP Rejection
December 27, 2012 2013/2 Gaz IS Rejection
December 27, 2012 2013/1 Gaz KR Rejection
November 8, 2012 2012/46 Gaz AU Rejection
November 2, 2012 2013/42 Gaz MC Rejection
October 31, 2012 2012/45 Gaz SG Rejection
August 15, 2012 2012/33 Gaz US Rejection
August 14, 2012 2012/36 Gaz Correction
August 13, 2012 2012/36 Gaz Correction
December 12, 2011 2012/29 Gaz GB Registration
Partial deletion

ID: 141122241